---
created: 2025-04-13
updated: 2025-04-13T10:51
id: d?`5azD]ar
specialty: cardio
specialty_id: 82
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/b&b::05-cardio::04-arrhythmias::06-antiarrhythmic-drugs
  - source/ak-step1-v11::
  - theme/firstaid::07-cardiovascular::05-pharm::12-16-antiarrythmics::14-class-3-potassium-channel-blockers
  - source/ak-step1-v11::
  - theme/ome::09-cardiac::04-electricity::05-anti-arrhythmics
  - source/ak-step1-v11::
  - source/ome-banner::basic-science::09-cardiac::25-arrhythmias
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::10-cardiac::19-class-iii-antiarrhythmics
  - source/ak-step1-v11::
  - theme/sketchypharm::02-cardio-&-renal::04-antiarrhythmics::03-class-iii
  - source/ak-step1-v11::
  - theme/uworld::100-999::900-999::901
  - source/ak-step1-v11::
  - theme/uworld::1000-9999::1000-1999::1507
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::cardio::pharmacology
  - source/ak-step2-v11::
  - theme/b&b::01-cardiology::pharm::cvs-pharm-1"
type: flashcard
---

# Question
Class III antiarrhythmics (K+ channel blockers) exert their effects by prolonging phase **2** and **3** of the myocardial action potential

---

# Answer
prolongs the action potential and effective refractory period